CollPlant Biotechnologies (CLGN) Competitors $2.32 -0.02 (-0.85%) As of 10:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLGN vs. INO, HYPR, PDEX, NSPR, OBIO, FONR, ZJYL, EDAP, NTRB, and VANIShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include Inovio Pharmaceuticals (INO), Hyperfine (HYPR), Pro-Dex (PDEX), InspireMD (NSPR), Orchestra BioMed (OBIO), Fonar (FONR), Jin Medical International (ZJYL), Edap Tms (EDAP), Nutriband (NTRB), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. Its Competitors Inovio Pharmaceuticals Hyperfine Pro-Dex InspireMD Orchestra BioMed Fonar Jin Medical International Edap Tms Nutriband Vivani Medical Inovio Pharmaceuticals (NASDAQ:INO) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk. Does the media prefer INO or CLGN? In the previous week, Inovio Pharmaceuticals and Inovio Pharmaceuticals both had 4 articles in the media. Inovio Pharmaceuticals' average media sentiment score of 0.73 beat CollPlant Biotechnologies' score of 0.64 indicating that Inovio Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inovio Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CollPlant Biotechnologies 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, INO or CLGN? CollPlant Biotechnologies has higher revenue and earnings than Inovio Pharmaceuticals. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$220K634.06-$107.25M-$2.61-1.01CollPlant Biotechnologies$2.40M12.28-$16.61M-$1.13-2.05 Do institutionals and insiders hold more shares of INO or CLGN? 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 2.3% of Inovio Pharmaceuticals shares are owned by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, INO or CLGN? Inovio Pharmaceuticals has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Do analysts recommend INO or CLGN? Inovio Pharmaceuticals presently has a consensus price target of $8.80, suggesting a potential upside of 235.24%. CollPlant Biotechnologies has a consensus price target of $11.50, suggesting a potential upside of 395.69%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Inovio Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29CollPlant Biotechnologies 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is INO or CLGN more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -541.34%. CollPlant Biotechnologies' return on equity of -94.08% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -163.32% -96.41% CollPlant Biotechnologies -541.34%-94.08%-68.62% SummaryCollPlant Biotechnologies beats Inovio Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.50M$3.36B$6.12B$10.64BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-2.0522.1586.1127.75Price / Sales12.28419.64588.17183.92Price / CashN/A47.1938.3262.20Price / Book1.9710.3912.976.80Net Income-$16.61M-$52.40M$3.30B$275.97M7 Day Performance-3.33%4.11%3.27%2.08%1 Month Performance-14.71%15.96%10.12%9.09%1 Year Performance-48.56%33.37%83.41%36.72% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies2.8495 of 5 stars$2.32-0.9%$11.50+395.7%-48.2%$29.50M$2.40M-2.0570Positive NewsAnalyst ForecastGap DownINOInovio Pharmaceuticals3.8086 of 5 stars$2.34-4.3%$8.80+276.9%-51.7%$124.09M$182.34K-0.89320Analyst ForecastHYPRHyperfine1.0775 of 5 stars$1.44-2.4%$1.28-10.6%+96.0%$112.76M$10.80M-2.76190News CoverageAnalyst ForecastPDEXPro-Dex3.0765 of 5 stars$33.83-0.2%$56.00+65.6%+18.5%$109.90M$66.59M12.49140News CoveragePositive NewsAnalyst ForecastNSPRInspireMD2.9468 of 5 stars$2.42flat$4.50+86.0%-8.7%$100.97M$7.07M-3.2350OBIOOrchestra BioMed3.1607 of 5 stars$2.43-1.2%$13.50+455.6%-42.6%$94.09M$2.64M-1.334News CoverageAnalyst ForecastFONRFonar1.5578 of 5 stars$15.14-0.1%N/A-1.9%$93.91M$104.35M12.31480ZJYLJin Medical InternationalN/A$0.58-2.2%N/A-83.0%$90.02M$23.50M0.00245Analyst ForecastGap UpEDAPEdap Tms3.1853 of 5 stars$2.32-3.1%$8.50+267.2%-17.2%$86.56M$63.02M-3.80230Analyst ForecastGap DownNTRBNutriband2.2387 of 5 stars$7.03-0.4%$13.00+84.9%+15.0%$84.57M$2.14M-2.4510News CoverageAnalyst ForecastVANIVivani Medical2.9983 of 5 stars$1.42+1.4%$4.00+181.7%+25.9%$84.13MN/A-3.1620 Related Companies and Tools Related Companies Inovio Pharmaceuticals Competitors Hyperfine Competitors Pro-Dex Competitors InspireMD Competitors Orchestra BioMed Competitors Fonar Competitors Jin Medical International Competitors Edap Tms Competitors Nutriband Competitors Vivani Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLGN) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
